Doxylamine Succinate and Pyridoxine Hydrochloride Tablet, Delayed Release
Category: Other
FDA status: To Be Discontinued · Last FDA update: Jan 12, 2026 · First posted: Jan 12, 2026 · 1 manufacturers, 1 listed presentations
As of Jan 12, 2026, the FDA lists Doxylamine Succinate and Pyridoxine Hydrochloride Tablet, Delayed Release as being discontinued. Of 1 manufacturer presentations, 1 Not specified.
| Presentation & package NDC | Manufacturer | Availability | FDA note |
|---|---|---|---|
| Doxylamine Succinate and Pyridoxine Hydrochloride, Tablet, Delayed Release, 10 mg; 10 mg (NDC 0378-4615-01) NDC 0378-4615-01 |
Mylan Pharmaceuticals Inc., a Viatris Company | Not specified | A business decision was made to discontinue manufacture of the drug. |
Related medications in shortage
Other Other medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.
Change log
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Cite this: “FDA drug-shortage status for Doxylamine Succinate and Pyridoxine Hydrochloride Tablet, Delayed Release (FDA data as of Jan 12, 2026). Shortage Watch, openFDA.”
Get an email when this record changes
One email, only when the FDA changes something for Doxylamine Succinate and Pyridoxine Hydrochloride Tablet, Delayed Release. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.
Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.
Embed a live status badge: /badge/doxylamine-succinate-and-pyridoxine-hydrochloride-f6c665.svg
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).